These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 10534492)

  • 1. The disappointing results of PTCA in the uraemic patient--are stents the answer?
    Haller C; Kübler W
    Nephrol Dial Transplant; 1999 Nov; 14(11):2582-4. PubMed ID: 10534492
    [No Abstract]   [Full Text] [Related]  

  • 2. Percutaneous coronary angioplasty (PTCA) or coronary artery bypass grafting (CABG)--which is the appropriate therapy of coronary artery disease in uraemic patients?
    Ivens K; Heering P; Leschke M; Grabensee B
    Nephrol Dial Transplant; 1996 Oct; 11(10):1949-51. PubMed ID: 8918703
    [No Abstract]   [Full Text] [Related]  

  • 3. How to diagnose and treat coronary artery disease in the uraemic patient: an update.
    Elsner D
    Nephrol Dial Transplant; 2001 Jun; 16(6):1103-8. PubMed ID: 11390705
    [No Abstract]   [Full Text] [Related]  

  • 4. Antithrombotic therapy in patients undergoing coronary angioplasty.
    Popma JJ; Coller BS; Ohman EM; Bittl JA; Weitz J; Kuntz RE; Leon MB
    Chest; 1995 Oct; 108(4 Suppl):486S-501S. PubMed ID: 7555198
    [No Abstract]   [Full Text] [Related]  

  • 5. Usefulness of platelet glycoprotein IIb/IIIa inhibitors in coronary stenting for reconstruction of complex lesions: procedural and 30 day outcome.
    Galassi AR; Russo G; Nicosia A; Tamburino C; Foti R; Rodi G; Calvi V; Gulizia G; Distefano G; Moshiri S; Giuffrida G
    Cardiologia; 1999 Jul; 44(7):639-45. PubMed ID: 10476589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Times they are a-changin.
    King SB
    JACC Cardiovasc Interv; 2012 Mar; 5(3):364-5. PubMed ID: 22440508
    [No Abstract]   [Full Text] [Related]  

  • 7. Clopidogrel and percutaneous coronary intervention.
    Cannon C
    Lancet; 2002 Jan; 359(9301):169. PubMed ID: 11809292
    [No Abstract]   [Full Text] [Related]  

  • 8. The value of selectivity.
    Colombo A; Stankovic G
    J Am Coll Cardiol; 2006 Feb; 47(4):719-20. PubMed ID: 16487834
    [No Abstract]   [Full Text] [Related]  

  • 9. [Percutaneous coronary angioplasty in diabetic patients: new prospects with drug-eluting stents].
    Warzee F; Legrand V; Scheen AJ
    Rev Med Liege; 2004 Dec; 59(12):711-6. PubMed ID: 15658058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. Evaluation of Platelet IIb/IIIa Inhibition in Stenting Investigators.
    Lincoff AM; Califf RM; Moliterno DJ; Ellis SG; Ducas J; Kramer JH; Kleiman NS; Cohen EA; Booth JE; Sapp SK; Cabot CF; Topol EJ
    N Engl J Med; 1999 Jul; 341(5):319-27. PubMed ID: 10423466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiplatelet rather than anticoagulant therapy with coronary stenting.
    More RS; Chauhan A
    Lancet; 1997 Jan; 349(9046):146-7. PubMed ID: 9111532
    [No Abstract]   [Full Text] [Related]  

  • 12. Variability in response to clopidogrel: where is the threshold for 'low response'?
    Dániel A; Pintér T; Horváth IG; Komócsi A
    Eur Heart J; 2007 Feb; 28(4):515-6; author reply 516. PubMed ID: 17289747
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug-eluting stents: some bare facts.
    Eisenberg MJ
    Lancet; 2004 Oct 23-29; 364(9444):1466-7. PubMed ID: 15500872
    [No Abstract]   [Full Text] [Related]  

  • 14. Preventing coronary restenosis and complications.
    Holmes DR
    N Engl J Med; 1997 Jun; 336(24):1748-9. PubMed ID: 9180094
    [No Abstract]   [Full Text] [Related]  

  • 15. Minimally invasive bypass surgery.
    Dragu RE
    N Engl J Med; 2002 Dec; 347(26):2165-8; author reply 2165-8. PubMed ID: 12501850
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term clopidogrel therapy in the drug-eluting stent era: beyond CREDO and PCI-CURE.
    Koh TW
    Eur Heart J; 2004 Aug; 25(15):1364; author reply 1364-5. PubMed ID: 15288165
    [No Abstract]   [Full Text] [Related]  

  • 17. Optimal treatment of acute coronary syndromes--an evolving strategy.
    Boden WE; McKay RG
    N Engl J Med; 2001 Jun; 344(25):1939-42. PubMed ID: 11419433
    [No Abstract]   [Full Text] [Related]  

  • 18. Interventions in cardiology: what does and does not work.
    King SB
    Am J Cardiol; 2000 Aug; 86(4B):3H-5H. PubMed ID: 11021249
    [No Abstract]   [Full Text] [Related]  

  • 19. [Coronary heart disease: news about stents and bypasses].
    Rassaf T; Albert A
    Dtsch Med Wochenschr; 2013 Jun; 138(23):1225-8. PubMed ID: 23720176
    [No Abstract]   [Full Text] [Related]  

  • 20. [Adjuvant therapy with a glycoprotein IIb-IIa inhibitor (abciximab) in coronary angioplasties with a high thrombotic risk].
    Matos V; Marques AM; Oliveira H; Ramos D; Lopes P; Camacho M; Gonsalves A
    Rev Port Cardiol; 1998 Dec; 17(12):1001-5. PubMed ID: 9973861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.